RGNT Latest Press Releases

-- July 20, 2026 --

Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology ACCESS Newswire 9:00 AM

-- July 15, 2026 --

Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch ACCESS Newswire 9:00 AM

-- June 17, 2026 --

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement ACCESS Newswire 9:06 PM

-- June 8, 2026 --

Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate ACCESS Newswire 8:32 AM

-- April 16, 2026 --

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon ACCESS Newswire 8:30 AM

-- March 17, 2026 --

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400% ACCESS Newswire 8:30 AM

-- February 24, 2026 --

Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update ACCESS Newswire 4:15 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software